Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
  • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
  • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
  • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
  • A61K31/47—Quinolines; Isoquinolines
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
  • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P9/00—Drugs for disorders of the cardiovascular system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P9/00—Drugs for disorders of the cardiovascular system
  • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P9/00—Drugs for disorders of the cardiovascular system
  • A61P9/06—Antiarrhythmics
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P9/00—Drugs for disorders of the cardiovascular system
  • A61P9/08—Vasodilators for multiple indications
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P9/00—Drugs for disorders of the cardiovascular system
  • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
  • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
  • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
  • C07D215/36—Sulfur atoms
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
  • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
  • C07D271/12—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
  • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
  • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
  • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
  • C07D333/30—Hetero atoms other than halogen
  • C07D333/34—Sulfur atoms
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
  • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
  • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
  • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
  • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Health & Medical Sciences (AREA)
• Medicinal Chemistry (AREA)
• Veterinary Medicine (AREA)
• Public Health (AREA)
• General Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• Pharmacology & Pharmacy (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Engineering & Computer Science (AREA)
• Cardiology (AREA)
• Chemical Kinetics & Catalysis (AREA)
• General Chemical & Material Sciences (AREA)
• Heart & Thoracic Surgery (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Epidemiology (AREA)
• Hospice & Palliative Care (AREA)
• Vascular Medicine (AREA)
• Urology & Nephrology (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
• Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
• Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
• Plural Heterocyclic Compounds (AREA)
• Quinoline Compounds (AREA)
• Pyridine Compounds (AREA)
• Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Applications Claiming Priority (1)

Publications (1)

Family

ID=7687941

Family Applications (1)

Country Status (41)

Families Citing this family (29)

Family Cites Families (13)

• 2001
  • 2001-06-12 DE DE10128331A patent/DE10128331A1/de not_active Withdrawn
• 2002
  • 2002-05-17 PE PE2002000419A patent/PE20021066A1/es not_active Application Discontinuation
  • 2002-05-21 OA OA1200300333A patent/OA12631A/fr unknown
  • 2002-05-31 HU HU0400159A patent/HUP0400159A3/hu unknown
  • 2002-05-31 PL PL02364371A patent/PL364371A1/xx not_active IP Right Cessation
  • 2002-05-31 DK DK02745333T patent/DK1399423T3/da active
  • 2002-05-31 UA UA2004010206A patent/UA75412C2/uk unknown
  • 2002-05-31 RS YU97703A patent/RS97703A/sr unknown
  • 2002-05-31 BR BR0210374-5A patent/BR0210374A/pt not_active Application Discontinuation
  • 2002-05-31 EE EEP200300558A patent/EE05196B1/xx not_active IP Right Cessation
  • 2002-05-31 DE DE50211213T patent/DE50211213D1/de not_active Expired - Lifetime
  • 2002-05-31 AT AT02745333T patent/ATE378318T1/de active
  • 2002-05-31 CZ CZ20033361A patent/CZ20033361A3/cs unknown
  • 2002-05-31 SK SK1522-2003A patent/SK15222003A3/sk unknown
  • 2002-05-31 EP EP02745333A patent/EP1399423B9/de not_active Expired - Lifetime
  • 2002-05-31 WO PCT/EP2002/005956 patent/WO2002100825A2/de active IP Right Grant
  • 2002-05-31 MX MXPA03010875A patent/MXPA03010875A/es active IP Right Grant
  • 2002-05-31 CA CA2450076A patent/CA2450076C/en not_active Expired - Fee Related
  • 2002-05-31 PT PT02745333T patent/PT1399423E/pt unknown
  • 2002-05-31 JP JP2003503594A patent/JP4422477B2/ja not_active Expired - Fee Related
  • 2002-05-31 ES ES02745333T patent/ES2295360T3/es not_active Expired - Lifetime
  • 2002-05-31 IL IL15924702A patent/IL159247A0/xx unknown
  • 2002-05-31 NZ NZ530081A patent/NZ530081A/en unknown
  • 2002-05-31 RU RU2004100302/04A patent/RU2293727C2/ru not_active IP Right Cessation
  • 2002-05-31 CN CNB028118502A patent/CN1247544C/zh not_active Expired - Fee Related
  • 2002-05-31 AU AU2002316939A patent/AU2002316939B2/en not_active Ceased
  • 2002-05-31 KR KR1020037016206A patent/KR100863924B1/ko not_active IP Right Cessation
  • 2002-06-10 TW TW091112464A patent/TWI304400B/zh not_active IP Right Cessation
  • 2002-06-10 AR ARP020102178A patent/AR036045A1/es active IP Right Grant
  • 2002-06-11 MY MYPI20022165A patent/MY138341A/en unknown
  • 2002-06-12 US US10/166,595 patent/US6903216B2/en not_active Expired - Lifetime
• 2003
  • 2003-07-08 TN TNPCT/EP2002/005956A patent/TNSN03134A1/en unknown
  • 2003-10-31 ZA ZA200308520A patent/ZA200308520B/en unknown
  • 2003-11-04 CR CR7140A patent/CR7140A/es not_active Application Discontinuation
  • 2003-12-03 EC EC2003004883A patent/ECSP034883A/es unknown
  • 2003-12-04 BG BG108415A patent/BG108415A/xx unknown
  • 2003-12-08 NO NO20035450A patent/NO20035450D0/no not_active Application Discontinuation
  • 2003-12-08 IL IL159247A patent/IL159247A/en not_active IP Right Cessation
  • 2003-12-10 MA MA27434A patent/MA27037A1/fr unknown
  • 2003-12-11 HR HR20031028A patent/HRP20031028A2/hr not_active Application Discontinuation
  • 2003-12-11 CO CO03108701A patent/CO5540283A2/es not_active Application Discontinuation
• 2004
  • 2004-10-20 HK HK04108195A patent/HK1065316A1/xx not_active IP Right Cessation
• 2005
  • 2005-02-08 US US11/052,959 patent/US7235664B2/en not_active Expired - Lifetime
• 2008
  • 2008-02-04 CY CY20081100143T patent/CY1107427T1/el unknown

Also Published As

Similar Documents